Clearstead Advisors
KRRO icon

Clearstead Advisors’s Korro Bio KRRO Stock Holding History

Clearstead Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252 Buy
+19
New +$236 ﹤0.01% 3126
2025
Q4 		– Sell
-18
Closed -$863 – 3026
2025
Q3 		$863 Buy
+18
New +$399 ﹤0.01% 2645

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Clearstead Advisors's KRRO Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Korro Bio (KRRO) in Q2 2026: 19 shares worth $252. The stake represents ﹤0.01% of the portfolio and ranks #3126 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in KRRO as recently as Q3 2025.

Clearstead Advisors first reported a position in KRRO in Q3 2025 and has held it in 2 quarters since. The position peaked at $863 in Q3 2025. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Clearstead Advisors held 19 shares of Korro Bio worth $252 as of Q2 2026.
  • Korro Bio was a new Clearstead Advisors position in Q2 2026.
  • Korro Bio made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3126 holding.
  • Clearstead Advisors first reported a position in Korro Bio in Q3 2025 and has held it in 2 quarters since.
  • Clearstead Advisors's Korro Bio position peaked at $863 in Q3 2025.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.